Skip to main
Genetic science research
George Mason University
News

Petricoin Conducting Protein Pathway Activation Mapping Of Tissue Cells Treated With Molecular Inhibitors

Elizabeth Grisham

Emanuel Petricoin, Professor, School of Systems Biology and Co-Director, Center for Applied Proteomics and Molecular Medicine (CAPMM), received funding from the University of North Carolina at Chapel Hill for the project: "Protein pathway activation mapping of tissue cells treated with molecular inhibitors."  

For this project, Petricoin will receive cell culture tissue cells and cell lysates from UNC/Springworks Therapeutics, Inc. CAPMM researchers will perform all aspects of the Reverse Phase Protein Array (RPPA) analysis including lysing, plating, printing, staining, imaging, and data extraction and analysis. Mason researchers will share RPPA data with UNC/Springworks Therapeutics, Inc. and jointly analyze it. 

Petricoin received $31,780 from the University of North Carolina at Chapel Hill for this project. Funding began in July 2021 and will end in July 2022. 

* The programs and services offered by George Mason University are open to all who seek them. George Mason does not discriminate on the basis of race, color, religion, ethnic national origin (including shared ancestry and/or ethnic characteristics), sex, disability, military status (including veteran status), sexual orientation, gender identity, gender expression, age, marital status, pregnancy status, genetic information, or any other characteristic protected by law. After an initial review of its policies and practices, the university affirms its commitment to meet all federal mandates as articulated in federal law, as well as recent executive orders and federal agency directives.